deltatrials
Terminated OBSERVATIONAL NCT03557749

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Monitoring of Immune and Microbial Reconstitution in Hematopoietic Cell Transplantation (HCT) and Novel Immunotherapies

Sponsor: Masonic Cancer Center, University of Minnesota

Conditions Acute-graft-versus-host Disease Allogenic Related Donors Cell Therapy/Immunotherapy Patients Chronic Graft-versus-host-disease Cytokine Release Syndrome Immune and Microbial Reconstitution Recurrent Malignancy Systemic Viral Infection
Interventions Apheresis Product Blood Sample Bronchoalveolar Lavage (BAL) fluid Final cellular product Gastrointestinal biopsy x 2-4 Skin biopsy Skin, mouth, and/or ocular swab Stool Sample Urine Sample
Updated 10 times since 2018 Last updated: Aug 16, 2023 Started: Sep 21, 2018 Primary completion: Jun 30, 2023 Completion: Aug 15, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Accrual goal met

Other terminated trials from Masonic Cancer Center, University of Minnesota

See all terminations from Masonic Cancer Center, University of Minnesota

Other Acute-graft-versus-host Disease trials with similar outcome

Browse all Acute-graft-versus-host Disease trials

A observational or N/A phase clinical study on Acute-graft-versus-host Disease and Allogenic Related Donors, this trial is terminated or withdrawn. The trial is conducted by Masonic Cancer Center, University of Minnesota and has accumulated 10 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jul 2018 – ~Oct 2018 · 3 months · monthly snapshotNot Yet Recruiting~Oct 2018 – ~Oct 2019 · 12 months · monthly snapshotRecruiting~Oct 2019 – ~Oct 2020 · 12 months · monthly snapshotRecruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotRecruiting~Jan 2021 – ~Feb 2022 · 13 months · monthly snapshotRecruiting~Feb 2022 – ~Feb 2023 · 12 months · monthly snapshotRecruiting~Feb 2023 – ~Sep 2023 · 7 months · monthly snapshotSuspended~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Sep 2023 — Jul 2024 [monthly]

    Terminated

    Status: Suspended → Terminated

  4. Feb 2023 — Sep 2023 [monthly]

    Suspended

    Status: Recruiting → Suspended

  5. Feb 2022 — Feb 2023 [monthly]

    Recruiting

▶ Show 5 earlier versions

  1. Jan 2021 — Feb 2022 [monthly]

    Recruiting

  2. Oct 2020 — Jan 2021 [monthly]

    Recruiting

  3. Oct 2019 — Oct 2020 [monthly]

    Recruiting

  4. Oct 2018 — Oct 2019 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  5. Jul 2018 — Oct 2018 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Masonic Cancer Center, University of Minnesota
Data source: Masonic Cancer Center, University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations